title: Effects of different mediators or cytokines and monoclonal antibodies to adhesion molecules on leukocyte adhesion in rat mesenteric venules.
abstract: Leukocyte adhesion (LA) to the endothelium of postcapillary venules is considered to be an important step in the inflammatory response. The recruitment of blood leukocytes into sites of inflammation involves a well-coordinated and dynamic sequence of events in which several cellular adhesion molecules (CAMs) and chemotactic cytokines play an active role. The aim of the present study was to elucidate receptor-mediated interaction in mesenteric venules of leukocyte rolling/adhesion and plasma leakage. We applied intravital microscopic techniques, with the help of an analogous video image processing system, to measure changes in the microvascular integrity. Rat monoclonal antibodies (MoAb) to different CAMs were administered before inflammatory stimuli were applied. Topical application of different doses of either lipo-polysaccharide (LPS), fMet-Leu-Phe, zymosan, complement C5a, Tnf-alpha, interleukin-1beta (IL-1beta), IL2 or IL-6 resulted in a dose-dependent increase in LA. The injection of a MoAb (1 mg/kg), 15 min prior to the LPS challenge, resulted in (1) total inhibition of LA, when MoAb to rat L-section, LFA1-beta and VLA-4 were used, (2) a moderate effect with LFA-1beta and Mac-1 MoAb, and (3) only a weak influence on LA by the MoAb to rat ICAM-1 (1 mg/kg). No effects were seen with IgG1 control MoAb. LA in acute models of inflammation can be regarded as a consequence of time-dependent differential effects of CAMs, as observed through the application of different MoAb.
authors.affiliation: Hoechst, Wiesbaden, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Seiffge
authors.forename: E
authors.initials: E
authors.lastname: Kremer
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D001783:Blood Flow Velocity; D002199:Capillary Permeability; D002448:Cell Adhesion / Q000187:drug effects*; D015815:Cell Adhesion Molecules / Q000276:immunology*; D015936:Complement C5a / Q000494:pharmacology; D005260:Female; D007376:Interleukin-2 / Q000494:pharmacology*; D007962:Leukocytes / Q000166:cytology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012212:Rheology; D013152:Splanchnic Circulation; D015054:Zymosan / Q000494:pharmacology
chemical_list: D000911:Antibodies, Monoclonal; D015815:Cell Adhesion Molecules; D007376:Interleukin-2; D008070:Lipopolysaccharides; D009240:N-Formylmethionine Leucyl-Phenylalanine; D015936:Complement C5a; D015054:Zymosan